Skip to main content
. 2021 Nov 3;9(11):1269. doi: 10.3390/vaccines9111269

Table 4.

Narrative description of cases reporting neurological symptoms included in the study.

Dose 1 Dose 2
  • -

    Male, 30 years old, reported vertigo in the 24 h following vaccination

  • -

    Female, 28 years old, reported bilateral paresthesia of the arms and hands, lasting 24 h

  • -

    Female, 29 years old, reported paresthesia in the left thigh for 4 days following vaccination

  • -

    Male, 28 years old, reported vertigo in the 24 h following vaccination

  • -

    Female, 27 years old, reported vertigo in the 24 h following vaccination

  • -

    Female, 31 years old, reported nervousness and confusion in the 24 h following vaccination

  • -

    Female, 29 years old, reported visual hallucinations with concurrent fever, the night after vaccination

  • -

    Female, 25 years old, reported sensory hypersensitivity in the 48 h following the vaccination